Actively Recruiting

Age: 18Years +
All Genders
NCT07428577

Tracking and Continuity of Care in Advanced HIV Disease

Led by Boston University · Updated on 2026-03-31

150

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

Sponsors

B

Boston University

Lead Sponsor

B

Bill and Melinda Gates Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

Despite the scale-up of HIV testing and the implementation of the universal test-and-treat policy, a substantial proportion of people living with HIV (PLHIV) continue to present with advanced HIV disease (AHD), defined by a CD4 count below 200 cells/µL and/or WHO clinical staging of stage 3 or 4. Global and regional analyses estimate that nearly half of hospitalized PLHIV meet criteria for AHD, with similar findings reported in South Africa. Patients with AHD face high risks of opportunistic infections, hospitalization, and mortality, and frequently disengage from care after discharge. This study aims to examine inpatient and post-discharge care pathways for individuals with AHD in South Africa, identify gaps in continuity of care between hospitals and primary healthcare (PHC) facilities, and generate evidence to inform strategies that strengthen linkage, retention, and long-term outcomes. A prospective cohort study with a nested process evaluation will be conducted at Helen Joseph Hospital, a large public tertiary facility in Johannesburg. Adult patients (≥18 years) admitted with HIV-related conditions and meeting AHD criteria will be consecutively enrolled once deemed clinically stable. Data will be collected through structured inpatient interviews, medical-record reviews, and follow-up telephone interviews at four- and eight-weeks post-discharge to assess linkage to PHC services, ART continuation, and readmissions. Quantitative data will be analyzed descriptively using standard statistical methods. This study will generate a detailed understanding of how patients with AHD transition from inpatient to outpatient HIV care, highlighting critical points where continuity of care fails. Findings will identify system- and patient-level barriers to effective linkage and retention and inform interventions to improve post-discharge outcomes. The study poses minimal risk to participants, involving only structured interviews and review of existing medical records, with no invasive procedures.

CONDITIONS

Official Title

Tracking and Continuity of Care in Advanced HIV Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Known HIV positive status
  • Admitted to inpatient care for an AHD-related illness
  • Aged 18 years and above
  • Able to provide written consent or consent using a thumbprint
  • Consent to be contacted after discharge and can provide contact information
Not Eligible

You will not qualify if you...

  • Confined to tuberculosis isolation ward or other wards for patients with acute infectious disease that requires isolation procedures
  • Not physically, mentally, or emotionally able to participate in the study prior to discharge, in the opinion of facility or study staff
  • Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Helen Joseph Hospital

Johannesburg, Gauteng, South Africa

Actively Recruiting

Loading map...

Research Team

E

Elizabeth Kachingwe

CONTACT

L

Linda Sande

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Tracking and Continuity of Care in Advanced HIV Disease | DecenTrialz